Furthermore, we identified that miR-383 was also targeting CIP2A. This interaction has been previously demonstrated in glioma cells, where miR-383 inhibited the expression of CIP2A and seized the proliferation and invasion of the cancer cells42. This evidence concerns the gene CIP2A and central nervous system cancer.